National Resilience snares Takeda plasma development and manufacturing dealnews2022-02-15T14:57:01+00:00February 15th, 2022|Fierce Pharma|
After Califf survives narrow Senate vote, FDA nominee looks set to be confirmed this weeknews2022-02-15T14:25:12+00:00February 15th, 2022|Fierce Pharma|
China CDMO Asymchem snaps up manufacturing specialist Snapdragon for $58M to boost US presencenews2022-02-15T13:34:14+00:00February 15th, 2022|Fierce Pharma|
ASCO GU: Merck, Eisai’s Lenvima fails to improve on Keytruda in bladder cancer as key Padcev readout nearsnews2022-02-15T13:21:37+00:00February 15th, 2022|Fierce Pharma|
Dermavant faces a perfect storm of pressures for tapinarof, but there is hope for the psoriasis drugnews2022-02-15T11:44:52+00:00February 15th, 2022|Fierce Pharma|
J&J’s Blue Jacket Fashion Show returns live to boost prostate cancer awarenessnews2022-02-15T09:53:47+00:00February 15th, 2022|Fierce Pharma|
ASCO GU: AstraZeneca, Merck’s Lynparza one-ups J&J’s Zejula with prostate cancer win regardless of gene mutationsnews2022-02-14T18:03:15+00:00February 14th, 2022|Fierce Pharma|
Vertex’s Trikafta pricing central to cystic fibrosis treatment disparities, study saysnews2022-02-14T16:59:19+00:00February 14th, 2022|Fierce Pharma|
Pfizer and Regeneron led pharma’s sales growth in Q4 while Teva, Biogen and Gilead laggednews2022-02-14T16:43:51+00:00February 14th, 2022|Fierce Pharma|
Novartis plots 400 job cuts in India after striking sales pact with Dr. Reddy’snews2022-02-14T15:30:31+00:00February 14th, 2022|Fierce Pharma|
